HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Low LDL's link to cancer is reverse causality: cancer lowers cholesterol, not vice versa

Louis Nervegna · Dec 21, 2023 · ♥ 5 reactions · 1 comments · original Facebook post
LDL, ApoB & lipid panelCancerHow to read research
AI summary & key facts

Louis explains why observational studies linking low LDL to cancer are not causal. Citing a Circulation review on reverse causality, he notes cholesterol declines before cancer diagnosis (likely from cancer-related inflammation), statin RCTs show no increase in cancer, and Mendelian randomization with an average of 52 years of lifetime exposure shows no higher cancer rates in people with genetically lower cholesterol.

Low LDL is associated with cancer in some observational studies.

Does this automatically mean that low LDL causes cancer? No, of course not. Everyone knows that correlation does not imply causation.

(In fact, when you look up the Wikipedia article on “correlation does not imply causation” it cites low LDL causing cancer as a classic example of this fallacy.)

So why is there an association between low LDL and cancer in the first year pace?

The most generally accepted explanation is the following:

Because studies show that cancer causes low LDL.

This is referred to as “reverse causality”, and is explained very well in this review article on the subject from the AHA journal Circulation.

Paper · Circulation · 2017Reverse Causality in Cardiovascular Epidemiological Researchahajournals.org

Quoted:

“It is notable that the observational association of low cholesterol levels with higher cancer risk has been shown to not be causal in statin trials that show no increase in cancer rates. [9] Furthermore, by using serial trial data, we demonstrated that cholesterol levels decline more quickly in advance of incident cancers than participants who remained cancer free [8], a finding in line with reverse causality and potentially attributable to systemic inflammation in cancers driving down circulating cholesterol levels.”

Quoted:

“Serial data reveal cholesterol declines in advance of cancer diagnosis [8].

Randomized trials of statins show no increase in cancer risk [9].

Genetic epidemiology [Mendellian randomization studies tracking 52yrs of lifetime on average] show those with lower cholesterol do not have higher cancer rates [8].”

#ldlHD #ldlcancerHD #cancerHD #statinscancerHD #reversecausalityHD #lowldlHD #ushapedcurveHD

Research cited

← newer: A zero CAC does not rule out plaque in symptomatic patients;older: PCSK9 inhibition may slow cardiometabolic aging beyond lower →